Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
A Correction to this paper has been published: https://doi.org/10.1038/s41591-021-01372-z.
Saved in:
Published in: | Nature medicine Vol. 27; no. 6; p. 1113 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
New York
Nature Publishing Group US
01-06-2021
Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A Correction to this paper has been published: https://doi.org/10.1038/s41591-021-01372-z. |
---|---|
Bibliography: | correction SourceType-Other Sources-1 content type line 63 ObjectType-Correction/Retraction-1 |
ISSN: | 1078-8956 1546-170X |
DOI: | 10.1038/s41591-021-01372-z |